Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry Paul C. Mayor, MD, Kevin H. Eng, PhD, Kelly L. Singel, BS, Scott I. Abrams, PhD, Kunle Odunsi, MD, PhD, Kirsten B. Moysich, PhD, Ramsay Fuleihan, MD, Elizabeth Garabedian, RN, Patricia Lugar, MD, Hans D. Ochs, MD, Francisco A. Bonilla, MD, PhD, Rebecca H. Buckley, MD, Kathleen E. Sullivan, MD, PhD, Zuhair K. Ballas, MD, Charlotte Cunningham-Rundles, MD, PhD, Brahm H. Segal, MD Journal of Allergy and Clinical Immunology Volume 141, Issue 3, Pages 1028-1035 (March 2018) DOI: 10.1016/j.jaci.2017.05.024 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Cancer incidence in both men and women in the USIDNET registry as well as age-adjusted cancer incidence obtained from the SEER database in men and women. We used SEER data to create an age-adjusted cancer incidence for the general population in 5-year increments. We applied SEER incidence data and adjusted for age to estimate the expected incidence of cancer. Journal of Allergy and Clinical Immunology 2018 141, 1028-1035DOI: (10.1016/j.jaci.2017.05.024) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions